NCT00001431View on ClinicalTrials.gov

A Phase I Trial of Gemcitabine and Radiation in Locally Advanced Unresectable Cancer of the Pancreas

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 28, 1995

Study Completion Date

November 30, 2000

Conditions
Gastrointestinal NeoplasmsPancreatic Neoplasms
Interventions
DRUG

gemcitabine

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00001431 - A Phase I Trial of Gemcitabine and Radiation in Locally Advanced Unresectable Cancer of the Pancreas | Biotech Hunter | Biotech Hunter